Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Depletion of C-reactive Protein by Therapeutic Apheresis (CRP-apheresis) in Ischemic Stroke

NCT04417231 is registered in ClinicalTrials.gov with Pentracor GmbH as lead sponsor.

NCT NCT04417231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04417231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Depletion of C-reactive Protein by Therapeutic Apheresis (CRP-apheresis) in Ischemic Stroke
Lead sponsor
Pentracor GmbH
Phase
Not applicable
Overall status
Terminated
Start date
January 28, 2021
Completion date
December 31, 2022
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, ischemic